ADMA Biologics (ADMA) Promotes Kaitlin Kestenberg to COO

April 2, 2024 5:21 PM EDT

Effective April 1, 2024 (the “Effective Date”), Kaitlin Kestenberg, former Senior Vice President, Compliance & Project Operations of ADMA Biologics (NASDAQ: ADMA), was promoted to Chief Operating Officer and Senior Vice President, Compliance of the Company (the “Promotion”).



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

8K, Corporate News, Management Changes